Severe asthma during childhood and adolescence: A longitudinal study
Morbidity and mortality associated with childhood asthma are driven disproportionately by children with severe asthma. However, it is not known from longitudinal studies whether children outgrow severe asthma. We sought to study prospectively whether well-characterized children with severe asthma ou...
Gespeichert in:
Veröffentlicht in: | Journal of allergy and clinical immunology 2020-01, Vol.145 (1), p.140-146.e9 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 146.e9 |
---|---|
container_issue | 1 |
container_start_page | 140 |
container_title | Journal of allergy and clinical immunology |
container_volume | 145 |
creator | Ross, Kristie R. Gupta, Ritika DeBoer, Mark D. Zein, Joe Phillips, Brenda R. Mauger, David T. Li, Chun Myers, Ross E. Phipatanakul, Wanda Fitzpatrick, Anne M. Ly, Ngoc P. Bacharier, Leonard B. Jackson, Daniel J. Celedón, Juan C. Larkin, Allyson Israel, Elliot Levy, Bruce Fahy, John V. Castro, Mario Bleecker, Eugene R. Meyers, Deborah Moore, Wendy C. Wenzel, Sally E. Jarjour, Nizar N. Erzurum, Serpil C. Teague, W.Gerald Gaston, Benjamin |
description | Morbidity and mortality associated with childhood asthma are driven disproportionately by children with severe asthma. However, it is not known from longitudinal studies whether children outgrow severe asthma.
We sought to study prospectively whether well-characterized children with severe asthma outgrow their asthma during adolescence.
Children with asthma were assessed at baseline with detailed questionnaires, allergy tests, and lung function tests and were reassessed annually for 3 years. The population was enriched for children with severe asthma, as assessed by the American Thoracic Society/European Respiratory Society guidelines, and subject classification was reassessed annually.
At baseline, 111 (59%) children had severe asthma. Year to year, there was a decrease in the proportion meeting the criteria for severe asthma. After 3 years, only 30% of subjects met the criteria for severe asthma (P < .001 compared with enrollment). Subjects experienced improvements in most indices of severity, including symptom scores, exacerbations, and controller medication requirements, but not lung function. Surprisingly, boys and girls were equally likely to has resolved asthma (33% vs 29%). The odds ratio in favor of resolution of severe asthma was 2.75 (95% CI, 1.02-7.43) for those with a peripheral eosinophil count of greater than 436 cells/μL.
In longitudinal analysis of this well-characterized cohort, half of the children with severe asthma no longer had severe asthma after 3 years; there was a stepwise decrease in the proportion meeting severe asthma criteria. Surprisingly, asthma severity decreased equally in male and female subjects. Peripheral eosinophilia predicted resolution. These data will be important for planning clinical trials in this population.
[Display omitted] |
doi_str_mv | 10.1016/j.jaci.2019.09.030 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2307133587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674919313181</els_id><sourcerecordid>2307133587</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-e20f09c31eb689112b86a41f5ab2faa685318475853d826fe3328538e082ec8e3</originalsourceid><addsrcrecordid>eNp9kM9KAzEQxoMotlZfwIPs0cvWSdLNZsVLKfUPFDyo55Ams23Kdrcmu4W-jc_ik5nS6lGYYWbgm4-ZHyHXFIYUqLhbDVfauCEDWgwhBocT0qdQ5KmQLDslfYCCpiIfFT1yEcIK4sxlcU56nArGhJR9Mn3DLXpMdGiXa53Yzrt6kZilq-yyaWyi65i2qTAYrA3eJ-Pvr6qpF67trKt1lYTY7C7JWamrgFfHOiAfj9P3yXM6e316mYxnqRkBtCkyKKEwnOJcyIJSNpdCj2iZ6TkrtRYy41SO8ixWK5kokXMWe4kgGRqJfEBuD74b33x2GFq1dvGwqtI1Nl1QjENOOc9kHqXsIDW-CcFjqTberbXfKQpqj0-t1B6f2uNTEINDXLo5-nfzNdq_lV9eUfBwEGD8cuvQq2DcHox1Hk2rbOP-8_8BWSOAnQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2307133587</pqid></control><display><type>article</type><title>Severe asthma during childhood and adolescence: A longitudinal study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ross, Kristie R. ; Gupta, Ritika ; DeBoer, Mark D. ; Zein, Joe ; Phillips, Brenda R. ; Mauger, David T. ; Li, Chun ; Myers, Ross E. ; Phipatanakul, Wanda ; Fitzpatrick, Anne M. ; Ly, Ngoc P. ; Bacharier, Leonard B. ; Jackson, Daniel J. ; Celedón, Juan C. ; Larkin, Allyson ; Israel, Elliot ; Levy, Bruce ; Fahy, John V. ; Castro, Mario ; Bleecker, Eugene R. ; Meyers, Deborah ; Moore, Wendy C. ; Wenzel, Sally E. ; Jarjour, Nizar N. ; Erzurum, Serpil C. ; Teague, W.Gerald ; Gaston, Benjamin</creator><creatorcontrib>Ross, Kristie R. ; Gupta, Ritika ; DeBoer, Mark D. ; Zein, Joe ; Phillips, Brenda R. ; Mauger, David T. ; Li, Chun ; Myers, Ross E. ; Phipatanakul, Wanda ; Fitzpatrick, Anne M. ; Ly, Ngoc P. ; Bacharier, Leonard B. ; Jackson, Daniel J. ; Celedón, Juan C. ; Larkin, Allyson ; Israel, Elliot ; Levy, Bruce ; Fahy, John V. ; Castro, Mario ; Bleecker, Eugene R. ; Meyers, Deborah ; Moore, Wendy C. ; Wenzel, Sally E. ; Jarjour, Nizar N. ; Erzurum, Serpil C. ; Teague, W.Gerald ; Gaston, Benjamin</creatorcontrib><description>Morbidity and mortality associated with childhood asthma are driven disproportionately by children with severe asthma. However, it is not known from longitudinal studies whether children outgrow severe asthma.
We sought to study prospectively whether well-characterized children with severe asthma outgrow their asthma during adolescence.
Children with asthma were assessed at baseline with detailed questionnaires, allergy tests, and lung function tests and were reassessed annually for 3 years. The population was enriched for children with severe asthma, as assessed by the American Thoracic Society/European Respiratory Society guidelines, and subject classification was reassessed annually.
At baseline, 111 (59%) children had severe asthma. Year to year, there was a decrease in the proportion meeting the criteria for severe asthma. After 3 years, only 30% of subjects met the criteria for severe asthma (P < .001 compared with enrollment). Subjects experienced improvements in most indices of severity, including symptom scores, exacerbations, and controller medication requirements, but not lung function. Surprisingly, boys and girls were equally likely to has resolved asthma (33% vs 29%). The odds ratio in favor of resolution of severe asthma was 2.75 (95% CI, 1.02-7.43) for those with a peripheral eosinophil count of greater than 436 cells/μL.
In longitudinal analysis of this well-characterized cohort, half of the children with severe asthma no longer had severe asthma after 3 years; there was a stepwise decrease in the proportion meeting severe asthma criteria. Surprisingly, asthma severity decreased equally in male and female subjects. Peripheral eosinophilia predicted resolution. These data will be important for planning clinical trials in this population.
[Display omitted]</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2019.09.030</identifier><identifier>PMID: 31622688</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>adolescence ; Adolescent ; Asthma - blood ; Asthma - drug therapy ; Asthma - pathology ; Child ; eosinophilia ; Eosinophils ; Female ; Humans ; Leukocyte Count ; Longitudinal Studies ; lung function ; Male ; Prospective Studies ; Severe asthma ; Severity of Illness Index</subject><ispartof>Journal of allergy and clinical immunology, 2020-01, Vol.145 (1), p.140-146.e9</ispartof><rights>2019 The Authors</rights><rights>Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-e20f09c31eb689112b86a41f5ab2faa685318475853d826fe3328538e082ec8e3</citedby><cites>FETCH-LOGICAL-c400t-e20f09c31eb689112b86a41f5ab2faa685318475853d826fe3328538e082ec8e3</cites><orcidid>0000-0001-8794-1062</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2019.09.030$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31622688$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ross, Kristie R.</creatorcontrib><creatorcontrib>Gupta, Ritika</creatorcontrib><creatorcontrib>DeBoer, Mark D.</creatorcontrib><creatorcontrib>Zein, Joe</creatorcontrib><creatorcontrib>Phillips, Brenda R.</creatorcontrib><creatorcontrib>Mauger, David T.</creatorcontrib><creatorcontrib>Li, Chun</creatorcontrib><creatorcontrib>Myers, Ross E.</creatorcontrib><creatorcontrib>Phipatanakul, Wanda</creatorcontrib><creatorcontrib>Fitzpatrick, Anne M.</creatorcontrib><creatorcontrib>Ly, Ngoc P.</creatorcontrib><creatorcontrib>Bacharier, Leonard B.</creatorcontrib><creatorcontrib>Jackson, Daniel J.</creatorcontrib><creatorcontrib>Celedón, Juan C.</creatorcontrib><creatorcontrib>Larkin, Allyson</creatorcontrib><creatorcontrib>Israel, Elliot</creatorcontrib><creatorcontrib>Levy, Bruce</creatorcontrib><creatorcontrib>Fahy, John V.</creatorcontrib><creatorcontrib>Castro, Mario</creatorcontrib><creatorcontrib>Bleecker, Eugene R.</creatorcontrib><creatorcontrib>Meyers, Deborah</creatorcontrib><creatorcontrib>Moore, Wendy C.</creatorcontrib><creatorcontrib>Wenzel, Sally E.</creatorcontrib><creatorcontrib>Jarjour, Nizar N.</creatorcontrib><creatorcontrib>Erzurum, Serpil C.</creatorcontrib><creatorcontrib>Teague, W.Gerald</creatorcontrib><creatorcontrib>Gaston, Benjamin</creatorcontrib><title>Severe asthma during childhood and adolescence: A longitudinal study</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>Morbidity and mortality associated with childhood asthma are driven disproportionately by children with severe asthma. However, it is not known from longitudinal studies whether children outgrow severe asthma.
We sought to study prospectively whether well-characterized children with severe asthma outgrow their asthma during adolescence.
Children with asthma were assessed at baseline with detailed questionnaires, allergy tests, and lung function tests and were reassessed annually for 3 years. The population was enriched for children with severe asthma, as assessed by the American Thoracic Society/European Respiratory Society guidelines, and subject classification was reassessed annually.
At baseline, 111 (59%) children had severe asthma. Year to year, there was a decrease in the proportion meeting the criteria for severe asthma. After 3 years, only 30% of subjects met the criteria for severe asthma (P < .001 compared with enrollment). Subjects experienced improvements in most indices of severity, including symptom scores, exacerbations, and controller medication requirements, but not lung function. Surprisingly, boys and girls were equally likely to has resolved asthma (33% vs 29%). The odds ratio in favor of resolution of severe asthma was 2.75 (95% CI, 1.02-7.43) for those with a peripheral eosinophil count of greater than 436 cells/μL.
In longitudinal analysis of this well-characterized cohort, half of the children with severe asthma no longer had severe asthma after 3 years; there was a stepwise decrease in the proportion meeting severe asthma criteria. Surprisingly, asthma severity decreased equally in male and female subjects. Peripheral eosinophilia predicted resolution. These data will be important for planning clinical trials in this population.
[Display omitted]</description><subject>adolescence</subject><subject>Adolescent</subject><subject>Asthma - blood</subject><subject>Asthma - drug therapy</subject><subject>Asthma - pathology</subject><subject>Child</subject><subject>eosinophilia</subject><subject>Eosinophils</subject><subject>Female</subject><subject>Humans</subject><subject>Leukocyte Count</subject><subject>Longitudinal Studies</subject><subject>lung function</subject><subject>Male</subject><subject>Prospective Studies</subject><subject>Severe asthma</subject><subject>Severity of Illness Index</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM9KAzEQxoMotlZfwIPs0cvWSdLNZsVLKfUPFDyo55Ams23Kdrcmu4W-jc_ik5nS6lGYYWbgm4-ZHyHXFIYUqLhbDVfauCEDWgwhBocT0qdQ5KmQLDslfYCCpiIfFT1yEcIK4sxlcU56nArGhJR9Mn3DLXpMdGiXa53Yzrt6kZilq-yyaWyi65i2qTAYrA3eJ-Pvr6qpF67trKt1lYTY7C7JWamrgFfHOiAfj9P3yXM6e316mYxnqRkBtCkyKKEwnOJcyIJSNpdCj2iZ6TkrtRYy41SO8ixWK5kokXMWe4kgGRqJfEBuD74b33x2GFq1dvGwqtI1Nl1QjENOOc9kHqXsIDW-CcFjqTberbXfKQpqj0-t1B6f2uNTEINDXLo5-nfzNdq_lV9eUfBwEGD8cuvQq2DcHox1Hk2rbOP-8_8BWSOAnQ</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Ross, Kristie R.</creator><creator>Gupta, Ritika</creator><creator>DeBoer, Mark D.</creator><creator>Zein, Joe</creator><creator>Phillips, Brenda R.</creator><creator>Mauger, David T.</creator><creator>Li, Chun</creator><creator>Myers, Ross E.</creator><creator>Phipatanakul, Wanda</creator><creator>Fitzpatrick, Anne M.</creator><creator>Ly, Ngoc P.</creator><creator>Bacharier, Leonard B.</creator><creator>Jackson, Daniel J.</creator><creator>Celedón, Juan C.</creator><creator>Larkin, Allyson</creator><creator>Israel, Elliot</creator><creator>Levy, Bruce</creator><creator>Fahy, John V.</creator><creator>Castro, Mario</creator><creator>Bleecker, Eugene R.</creator><creator>Meyers, Deborah</creator><creator>Moore, Wendy C.</creator><creator>Wenzel, Sally E.</creator><creator>Jarjour, Nizar N.</creator><creator>Erzurum, Serpil C.</creator><creator>Teague, W.Gerald</creator><creator>Gaston, Benjamin</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8794-1062</orcidid></search><sort><creationdate>202001</creationdate><title>Severe asthma during childhood and adolescence: A longitudinal study</title><author>Ross, Kristie R. ; Gupta, Ritika ; DeBoer, Mark D. ; Zein, Joe ; Phillips, Brenda R. ; Mauger, David T. ; Li, Chun ; Myers, Ross E. ; Phipatanakul, Wanda ; Fitzpatrick, Anne M. ; Ly, Ngoc P. ; Bacharier, Leonard B. ; Jackson, Daniel J. ; Celedón, Juan C. ; Larkin, Allyson ; Israel, Elliot ; Levy, Bruce ; Fahy, John V. ; Castro, Mario ; Bleecker, Eugene R. ; Meyers, Deborah ; Moore, Wendy C. ; Wenzel, Sally E. ; Jarjour, Nizar N. ; Erzurum, Serpil C. ; Teague, W.Gerald ; Gaston, Benjamin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-e20f09c31eb689112b86a41f5ab2faa685318475853d826fe3328538e082ec8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>adolescence</topic><topic>Adolescent</topic><topic>Asthma - blood</topic><topic>Asthma - drug therapy</topic><topic>Asthma - pathology</topic><topic>Child</topic><topic>eosinophilia</topic><topic>Eosinophils</topic><topic>Female</topic><topic>Humans</topic><topic>Leukocyte Count</topic><topic>Longitudinal Studies</topic><topic>lung function</topic><topic>Male</topic><topic>Prospective Studies</topic><topic>Severe asthma</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ross, Kristie R.</creatorcontrib><creatorcontrib>Gupta, Ritika</creatorcontrib><creatorcontrib>DeBoer, Mark D.</creatorcontrib><creatorcontrib>Zein, Joe</creatorcontrib><creatorcontrib>Phillips, Brenda R.</creatorcontrib><creatorcontrib>Mauger, David T.</creatorcontrib><creatorcontrib>Li, Chun</creatorcontrib><creatorcontrib>Myers, Ross E.</creatorcontrib><creatorcontrib>Phipatanakul, Wanda</creatorcontrib><creatorcontrib>Fitzpatrick, Anne M.</creatorcontrib><creatorcontrib>Ly, Ngoc P.</creatorcontrib><creatorcontrib>Bacharier, Leonard B.</creatorcontrib><creatorcontrib>Jackson, Daniel J.</creatorcontrib><creatorcontrib>Celedón, Juan C.</creatorcontrib><creatorcontrib>Larkin, Allyson</creatorcontrib><creatorcontrib>Israel, Elliot</creatorcontrib><creatorcontrib>Levy, Bruce</creatorcontrib><creatorcontrib>Fahy, John V.</creatorcontrib><creatorcontrib>Castro, Mario</creatorcontrib><creatorcontrib>Bleecker, Eugene R.</creatorcontrib><creatorcontrib>Meyers, Deborah</creatorcontrib><creatorcontrib>Moore, Wendy C.</creatorcontrib><creatorcontrib>Wenzel, Sally E.</creatorcontrib><creatorcontrib>Jarjour, Nizar N.</creatorcontrib><creatorcontrib>Erzurum, Serpil C.</creatorcontrib><creatorcontrib>Teague, W.Gerald</creatorcontrib><creatorcontrib>Gaston, Benjamin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ross, Kristie R.</au><au>Gupta, Ritika</au><au>DeBoer, Mark D.</au><au>Zein, Joe</au><au>Phillips, Brenda R.</au><au>Mauger, David T.</au><au>Li, Chun</au><au>Myers, Ross E.</au><au>Phipatanakul, Wanda</au><au>Fitzpatrick, Anne M.</au><au>Ly, Ngoc P.</au><au>Bacharier, Leonard B.</au><au>Jackson, Daniel J.</au><au>Celedón, Juan C.</au><au>Larkin, Allyson</au><au>Israel, Elliot</au><au>Levy, Bruce</au><au>Fahy, John V.</au><au>Castro, Mario</au><au>Bleecker, Eugene R.</au><au>Meyers, Deborah</au><au>Moore, Wendy C.</au><au>Wenzel, Sally E.</au><au>Jarjour, Nizar N.</au><au>Erzurum, Serpil C.</au><au>Teague, W.Gerald</au><au>Gaston, Benjamin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe asthma during childhood and adolescence: A longitudinal study</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2020-01</date><risdate>2020</risdate><volume>145</volume><issue>1</issue><spage>140</spage><epage>146.e9</epage><pages>140-146.e9</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Morbidity and mortality associated with childhood asthma are driven disproportionately by children with severe asthma. However, it is not known from longitudinal studies whether children outgrow severe asthma.
We sought to study prospectively whether well-characterized children with severe asthma outgrow their asthma during adolescence.
Children with asthma were assessed at baseline with detailed questionnaires, allergy tests, and lung function tests and were reassessed annually for 3 years. The population was enriched for children with severe asthma, as assessed by the American Thoracic Society/European Respiratory Society guidelines, and subject classification was reassessed annually.
At baseline, 111 (59%) children had severe asthma. Year to year, there was a decrease in the proportion meeting the criteria for severe asthma. After 3 years, only 30% of subjects met the criteria for severe asthma (P < .001 compared with enrollment). Subjects experienced improvements in most indices of severity, including symptom scores, exacerbations, and controller medication requirements, but not lung function. Surprisingly, boys and girls were equally likely to has resolved asthma (33% vs 29%). The odds ratio in favor of resolution of severe asthma was 2.75 (95% CI, 1.02-7.43) for those with a peripheral eosinophil count of greater than 436 cells/μL.
In longitudinal analysis of this well-characterized cohort, half of the children with severe asthma no longer had severe asthma after 3 years; there was a stepwise decrease in the proportion meeting severe asthma criteria. Surprisingly, asthma severity decreased equally in male and female subjects. Peripheral eosinophilia predicted resolution. These data will be important for planning clinical trials in this population.
[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31622688</pmid><doi>10.1016/j.jaci.2019.09.030</doi><orcidid>https://orcid.org/0000-0001-8794-1062</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-6749 |
ispartof | Journal of allergy and clinical immunology, 2020-01, Vol.145 (1), p.140-146.e9 |
issn | 0091-6749 1097-6825 |
language | eng |
recordid | cdi_proquest_miscellaneous_2307133587 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | adolescence Adolescent Asthma - blood Asthma - drug therapy Asthma - pathology Child eosinophilia Eosinophils Female Humans Leukocyte Count Longitudinal Studies lung function Male Prospective Studies Severe asthma Severity of Illness Index |
title | Severe asthma during childhood and adolescence: A longitudinal study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A27%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20asthma%20during%20childhood%20and%20adolescence:%20A%C2%A0longitudinal%20study&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Ross,%20Kristie%20R.&rft.date=2020-01&rft.volume=145&rft.issue=1&rft.spage=140&rft.epage=146.e9&rft.pages=140-146.e9&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2019.09.030&rft_dat=%3Cproquest_cross%3E2307133587%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2307133587&rft_id=info:pmid/31622688&rft_els_id=S0091674919313181&rfr_iscdi=true |